Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Mittelständische Beteiligungsgesellschaft Thüringen

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 6
Average round size
info
The average size of a deal this fund participated in
$351K
Portfolio companies 6
Lead investments 1
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Software
  • Health Care
  • iOS
  • Communities
  • Video Chat

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Mittelständische Beteiligungsgesellschaft Thüringen:
Typical Co-investors
Mittelständische Beteiligungsgesellschaft Thüringen is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Mittelständische Beteiligungsgesellschaft Thüringen:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Germany
Funds with similar focus located in Germany:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Capria Ventures Seattle, United States, Washington
Fibrotic Ventures Atlanta, Georgia, United States
Ginni International China, Hong Kong, Hong Kong Island
Harbour China, Shanghai
ICON Continuity Fund -
Inventure Capital, Madison Madison, United States, Wisconsin
Jimin Touzi China, Hangzhou, Zhejiang
KDB Bank -
Kester Capital England, London, United Kingdom
Lang Sheng Investment China, Shanghai
Launch TN Impact Fund -
Newsion Venture Capital Beijing, Beijing, China
ROK Capital -
Skandia.se Stockholm, Stockholm County, Sweden
Sunstone Life Science Ventures Copenhagen, Denmark, Hovedstaden
Tickets.com California, Costa Mesa, United States
Tiger Holding Norway, Oslo
Toyota Tunas -
Unicom Venture Capital Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Influnate

Fashion
Payments
Social Network
18 Dec 2020 Berlin, Berlin, Germany

Dynamic42

Health Care
Medical
Pharmaceutical
06 Apr 2020 Jena, Thuringen, Germany

BioTeSys

Biotechnology
Health Care
$608K10 May 2007 Germany, Bavaria, Germany

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Mittelständische Beteiligungsgesellschaft Thüringen?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 6
Average round size 351K
Peak activity year 2020
Lead investments 1
Group Appearance index 0.83

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Influnate

Fashion
Payments
Social Network
18 Dec 2020 Berlin, Berlin, Germany

Dynamic42

Health Care
Medical
Pharmaceutical
06 Apr 2020 Jena, Thuringen, Germany

BioTeSys

Biotechnology
Health Care
$608K10 May 2007 Germany, Bavaria, Germany
Crunchbase icon

Content report

The following text will be sent to our editors: